Drugs / APEX-002-A02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06141876 | Dec 2023 → Jun 2025 | major depressive disorder, post-traumatic stress disorder | Apex Labs Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APEX-002-A02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06141876 ↗ |